CAM
NVAX icon

Close Asset Management’s Novavax NVAX Stock Holding History

Close Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
50
– – ﹤0.01% 286
2025
Q4 		$0 Hold
50
– – ﹤0.01% 284
2025
Q3 		$0 Hold
50
– – ﹤0.01% 292
2025
Q2 		$0 Hold
50
– – ﹤0.01% 274
2025
Q1 		$0 Hold
50
– – ﹤0.01% 273
2024
Q4 		$0 Hold
50
– – ﹤0.01% 264
2024
Q3 		$1K Hold
50
– – ﹤0.01% 257
2024
Q2 		$1K Buy
+50
New +$503 ﹤0.01% 254
2023
Q2 		– Sell
-1,260
Closed -$9K – 256
2023
Q1 		$9K Sell
1,260
-3,600
-74% -$33.1K ﹤0.01% 207
2022
Q4 		$50K Sell
4,860
-3,400
-41% -$60K ﹤0.01% 130
2022
Q3 		$151K Sell
8,260
-1,110
-12% -$48.1K 0.01% 94
2022
Q2 		$482K Buy
+9,370
New +$485K 0.02% 75

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Close Asset Management's NVAX Position: Q1 2026 in Review

Close Asset Management held its Novavax (NVAX) position steady in Q1 2026 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #286.

Close Asset Management first reported a position in NVAX in Q2 2022 and has held it in 12 quarters since. The position peaked at $482K in Q2 2022. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Close Asset Management held 50 shares of Novavax worth $0 as of Q1 2026.
  • Close Asset Management left its Novavax share count unchanged in Q1 2026.
  • Novavax made up ﹤0.01% of Close Asset Management's portfolio in Q1 2026, its #286 holding.
  • Close Asset Management first reported a position in Novavax in Q2 2022 and has held it in 12 quarters since.
  • Close Asset Management's Novavax position peaked at $482K in Q2 2022.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.